Transgenic mice carrying a tetracycline-inducible, truncated transforming growth factor beta receptor (TβRII)

被引:14
作者
Frugier, T
Koishi, K
Matthaei, KI
McLennan, IS
机构
[1] Univ Otago, Sch Med Sci, Dept Anat & Struct Biol, Neuromuscular Res Grp, Dunedin, New Zealand
[2] John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 0200, Australia
关键词
mouse; transgenic; dominant negative receptor; transforming growth factor-beta; doxycycline; tetracycline-inducible expression; neuron;
D O I
10.1002/gene.20115
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transforming growth factor-betas (TGF beta s) have multiple roles, making genetic analysis of their functions difficult. We therefore developed transgenic mouse lines to disrupt TGF beta signaling using a mechanism that is inducible, reversible, and cell-type specific. The transgenic mouse lines carry an EGFP-pBi-DeltaT-betaRII construct (PTR). The Delta T beta RII element codes for a dominant-negative receptor that is known to disrupt TGF beta signaling. The Delta T beta RII has a c-myc tag. The transgene was silent in the PTR mice, with expression of both EGFP and Delta T beta RII occurring when the PTR mice were crossed with mice that express the tetracycline transactivator (CMV-tTA). The expression of EGFP was repressed by the addition of doxycycline to the drinking water of the PTRxCMV-tTA mice. The PTR mice were then crossed with neuron-specific-tTA mice. Expression of the Delta T beta RII transgene in these mice led to an upregulation of native TGF beta receptor expression, suggesting that neurons can modulate their responsiveness to TGF beta s. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 19 条
[1]   COREGULATION OF 2 GENE ACTIVITIES BY TETRACYCLINE VIA A BIDIRECTIONAL PROMOTER [J].
BARON, U ;
FREUNDLIEB, S ;
GOSSEN, M ;
BUJARD, H .
NUCLEIC ACIDS RESEARCH, 1995, 23 (17) :3605-3606
[2]   Transgenic animals with inducible, targeted gene expression in brain [J].
Chen, JS ;
Kelz, MB ;
Zeng, GQ ;
Sakai, N ;
Steffen, C ;
Shockett, PE ;
Picciotto, MR ;
Duman, RS ;
Nestler, EJ .
MOLECULAR PHARMACOLOGY, 1998, 54 (03) :495-503
[3]   Tgfβ2-/-Tgfβ3-/- double knockout mice display severe midline fusion defects and early embryonic lethality [J].
Dünker, N ;
Krieglstein, K .
ANATOMY AND EMBRYOLOGY, 2002, 206 (1-2) :73-83
[4]   ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT [J].
EVAN, GI ;
LEWIS, GK ;
RAMSAY, G ;
BISHOP, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3610-3616
[5]  
FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085
[6]   TEMPORAL CONTROL OF GENE-EXPRESSION IN TRANSGENIC MICE BY A TETRACYCLINE-RESPONSIVE PROMOTER [J].
FURTH, PA ;
STONGE, L ;
BOGER, H ;
GRUSS, P ;
GOSSEN, M ;
KISTNER, A ;
BUJARD, H ;
HENNIGHAUSEN, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9302-9306
[7]   PERSISTENT EFFECT OF TGF-BETA-1 ON EXTRACELLULAR-MATRIX GENE-EXPRESSION IN HUMAN DERMAL FIBROBLASTS [J].
ISHIKAWA, O ;
YAMAKAGE, A ;
LEROY, EC ;
TROJANOWSKA, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (01) :232-238
[8]   Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice [J].
Kistner, A ;
Gossen, M ;
Zimmermann, F ;
Jerecic, J ;
Ullmer, C ;
Lubbert, H ;
Bujard, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10933-10938
[9]  
LAWLER S, 1994, DEVELOPMENT, V120, P165
[10]   TGF-β knockout and dominant-negative receptor transgenic mice [J].
Letterio, JJ ;
Böttinger, EP .
MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) :161-167